New drug shows promise for Long-Term hair regrowth in alopecia areata
Disease control
Ongoing
This study looks at the long-term safety and effectiveness of a drug called CTP-543 for adults with moderate to severe alopecia areata, a condition that causes patchy hair loss. About 1,000 people who already completed 24 weeks of treatment in a prior CTP-543 trial will continue …
Phase: PHASE2, PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated May 17, 2026 11:33 UTC